Search Within

Lakshmi Vulimiri Ramanathan

Formats
  1. Journal Article (49)
  2. Meeting Abstract (17)
  3. Book Section (3)
  4. Research Letter (3)
  5. Miscellaneous (2)
  6. Book Whole (1)
  7. Correspondence (1)
  8. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (77)
  2. Department of Medicine (35)
  3. Hematologic Malignancies, Division of (26)
  4. Center for Hematologic Malignancies (23)
  5. Survivorship Research (22)
  6. Epidemiology and Biostatistics (20)

More Groups

People
  1. Melissa Pessin-Minsley (18)
  2. Martin Fleisher (17)
  3. Gunjan Shah (16)
  4. Kazunori Murata (15)
  5. David Chung (14)
  6. Sergio Giralt (13)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (10)
  6. 2020 (10)

More Years

Publications
  1. Blood (6)
  2. Journal of Applied Laboratory Medicine (6)
  3. Clinical Chemistry (4)
  4. Cancer Biomarkers: Clinical Aspects and Laboratory Determination (3)
  5. Clinica Chimica Acta (3)
  6. Clinical Biochemistry (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Amer Assoc Clinical Chemistry (6)
  3. American Society of Hematology (6)
  4. Oxford University Press (6)
  5. Elsevier Science BV (5)
  6. American Association for Clinical Chemistry (4)

More Publishers

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of humoral response to SARS-CoV-2 vaccination after hematopoietic cell transplantation and CAR T-cell therapy
    Journal Article

    Tamari, R.; Politikos, I.; Knorr, D. A.; Vardhana, S. A.; Young, J. C.; Marcello, L. T.; Doddi, S.; Devlin, S. M.; Ramanathan, L. V.; Pessin, M. S.; more...
    Blood Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Disease- and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies
    Journal Article

    Chung, D. J.; Shah, G. L.; Devlin, S. M.; Ramanathan, L. V.; Doddi, S.; Pessin, M. S.; Hoover, E.; Marcello, L. T.; Young, J. C.; Boutemine, S. R.; more...
    Blood Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • The New York State SARS-CoV-2 Testing Consortium: Regional communication in response to the COVID-19 pandemic
    Journal Article

    Crawford, J. M.; Aguero-Rosenfeld, M. E.; Aifantis, I.; Cadoff, E. M.; Cangiarella, J. F.; Cordon-Cardo, C.; Cushing, M.; Firpo-Betancourt, A.; Fox, A. S.; Furuya, Y.; more...
    Academic Pathology (2021)

    Fulltext@MSK | Save
  • Lifetime pesticide use and monoclonal gammopathy of undetermined significance in a prospective cohort of male farmers
    Journal Article

    Hofmann, J. N.; Beane Freeman, L. E.; Murata, K.; Andreotti, G.; Shearer, J. J.; Thoren, K.; Ramanathan, L.; Parks, C. G.; Koutros, S.; Lerro, C. C.; more...
    Environmental Health Perspectives (2021)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) in cerebrospinal fluid (CSF) as a predictor of survival in CNS metastases
    Meeting Abstract

    Diaz, M.; Singh, P.; Kotchekov, I.; Skakodub, A.; Reiner, A.; Panageas, K.; Ramanathan, L.; Pentsova, E.
    Neuro-Oncology Advances (2020)

    Fulltext@MSK | Save
  • Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma: final results from a clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Diamond, B.; Salcedo, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Confounding hyponatremia and hypochloremia in a cancer patient
    Journal Article

    Erdman, P.; Ramanathan, L.; Fleisher, M.; Pessin, M.
    Journal of Applied Laboratory Medicine (2020)

    Fulltext@MSK | Save